BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8065701)

  • 41. [Suppression effects of interleukin-10 on mouse herpetic stromal keratitis].
    Xia LK; Gao DW; Pu W; Zhang JS
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):592-6. PubMed ID: 14766072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection.
    Gangappa S; Deshpande SP; Rouse BT
    Eur J Immunol; 1999 Nov; 29(11):3674-82. PubMed ID: 10556823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis.
    Thomas J; Gangappa S; Kanangat S; Rouse BT
    J Immunol; 1997 Feb; 158(3):1383-91. PubMed ID: 9013983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice.
    Deshpande SP; Zheng M; Daheshia M; Rouse BT
    J Virol; 2000 Apr; 74(8):3517-24. PubMed ID: 10729125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity causing blindness: five different paths to herpes stromal keratitis.
    Streilein JW; Dana MR; Ksander BR
    Immunol Today; 1997 Sep; 18(9):443-9. PubMed ID: 9293161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A quantitative assay of retrograde transported HSV in the trigeminal ganglion.
    Carter SR; Pereira L; Paz P; LaVail JH
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1934-9. PubMed ID: 1316334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice.
    Chang E; Galle L; Maggs D; Estes DM; Mitchell WJ
    J Virol; 2000 Dec; 74(24):11832-40. PubMed ID: 11090183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis.
    Yun H; Rowe AM; Lathrop KL; Harvey SA; Hendricks RL
    J Virol; 2014 Jul; 88(14):7870-80. PubMed ID: 24789786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of HSV-1 antigen distribution in the cornea with clinical characteristics of herpetic stromal keratitis.
    Zhao G; Chen M; Liu T; Sun SY; Zhao J; Xie LX
    Eur J Ophthalmol; 2012; 22 Suppl 7():S40-5. PubMed ID: 22020985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.
    Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Central Role for Sympathetic Nerves in Herpes Stromal Keratitis in Mice.
    Yun H; Lathrop KL; Hendricks RL
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1749-56. PubMed ID: 27070108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.
    Heiligenhaus A; Li H; Schmitz A; Wasmuth S; Bauer D
    Clin Exp Immunol; 2005 Oct; 142(1):180-7. PubMed ID: 16178874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
    Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Amniotic membrane transplantation improves herpetic keratitis by local and not by systemic effects].
    Heiligenhaus A; Bauer D; Wasmuth S; Steuhl KP
    Ophthalmologe; 2003 Mar; 100(3):209-15. PubMed ID: 12640550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delayed type hypersensitivity in the pathogenesis of recurrent herpes stromal keratitis.
    Hawthorne KM; Dana R; Chodosh J
    Semin Ophthalmol; 2011; 26(4-5):246-50. PubMed ID: 21958170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aggravation of herpetic stromal keratitis after murine epidermal grown factor topical application.
    Romano A; Peisich A; Wasserman D; Gamus D
    Cornea; 1994 Mar; 13(2):167-72. PubMed ID: 8156789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis].
    Xia LK; Zhang JS; Chen XL; Wang AY
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):403-8. PubMed ID: 15938803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.
    Bauer D; Mrzyk S; Van Rooijen N; Steuhl KP; Heiligenhaus A
    Exp Eye Res; 2001 Mar; 72(3):261-9. PubMed ID: 11180975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis.
    Maertzdorf J; Verjans GM; Remeijer L; van der Kooi A; Osterhaus AD
    J Infect Dis; 2003 Feb; 187(4):550-8. PubMed ID: 12599071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.